Serial ctDNA testing service to track cancer progression and treatment response over time. Enables early detection of relapse before clinical or radiographic changes.
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Biopsense Oy
Finland · 1 relevant product
Beijing Diagreat Biotechnologies Co., Ltd
China · 1 relevant product
DMB Diagnostics
Germany · 2 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 2 relevant products
Wuhan Landing Intelligence Medical Co.,Ltd
China · 1 relevant product
Accurate International Biotechnology (Guangzhou) Co.,Ltd
China · 1 relevant product
U-GEN BIOTECHNOLOGY INC.
China · 1 relevant product
Feipu Intelligent Technology (Shanghai) Co., Ltd.
China · 1 relevant product
GENETRON HEALTH (BEIJING) CO., LTD
China · 1 relevant product
See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
11 of 11 closest product alternatives
Biopsense Oy · Finland
Comprehensive diagnostic service utilizing liquid biopsy technology for cancer detection, monitoring, and treatment response evaluation. Supports oncologists in selecting optimal cancer medications and detecting drug resistance through frequent, non-invasive blood sampling.
Beijing Diagreat Biotechnologies Co., Ltd · China
Comprehensive genetic testing service supporting precision drug therapy and personalized medicine applications. Integrates molecular analysis with therapeutic drug monitoring for comprehensive patient profiling.
DMB Diagnostics · Germany
A laboratory service for processing blood samples and analyzing circulating tumour cells from research sites. Results are returned with research data within approximately five working days.
DMB Diagnostics · Germany
An in-house sample processing service for research sites that submits blood samples for circulating tumour cell analysis and returns research data within approximately 5 working days. This research use only service supports investigation of tumour biology and therapeutic response.
BioChain (Beijing) Science & Technology. Inc. · China
Comprehensive laboratory testing service for hepatocellular carcinoma early detection and surveillance. This service integrates gene methylation testing with clinical assessment protocols for liver cancer screening. The service is accredited through continuous external quality assessment programs.
Wuhan Landing Intelligence Medical Co.,Ltd · China
Professional laboratory testing service provided by the company for cervical cancer screening and related diagnostic applications. This service supports the Landing AI+ cloud diagnostic technology and is integrated with their screening platform.
Accurate International Biotechnology (Guangzhou) Co.,Ltd · China
A personalized testing service using patient-derived organoids to evaluate drug efficacy and identify optimal therapeutic candidates for individual cancer treatment protocols.
U-GEN BIOTECHNOLOGY INC. · China
Comprehensive molecular diagnostic services delivered through accredited reference laboratories. Provides end-user diagnostic testing for genetic diseases, cancer screening, and chronic disease detection.
BioChain (Beijing) Science & Technology. Inc. · China
Clinical laboratory testing service for colorectal cancer early detection using gene methylation methodology. This service is provided through affiliated medical testing laboratories with continuous proficiency certification. The service is integrated into hospital networks and supported by medical insurance coverage.
Feipu Intelligent Technology (Shanghai) Co., Ltd. · China
A medical service providing whole genome DNA testing using proprietary detection algorithms for disease early screening and prenatal early screening applications. The service offers comprehensive genomic analysis to support clinical decision-making and early disease detection.
GENETRON HEALTH (BEIJING) CO., LTD · China
Digital pathology and tissue analysis service for cancer specimen evaluation. Integrates imaging and genomic data for comprehensive diagnosis. Provides expert interpretation and clinical recommendations.
© 2026 Suplivia · Home · Browse Products